Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

Similar articles for PubMed (Select 17414931)

1.

Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya.

Hawkins C, Achenbach C, Fryda W, Ngare D, Murphy R.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):304-10.

PMID:
17414931
2.

Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya.

Muhula SO, Peter M, Sibhatu B, Meshack N, Lennie K.

Pan Afr Med J. 2015 Jan 22;20:63. doi: 10.11604/pamj.2015.20.63.4865. eCollection 2015.

3.

Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.

Duber HC, Dansereau E, Masters SH, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masiye F, Njuguna P, Odeny T, Okiro E, Roberts DA, Gakidou E.

PLoS One. 2015 Mar 25;10(3):e0120350. doi: 10.1371/journal.pone.0120350. eCollection 2015.

4.

Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria.

Abah IO, Darin KM, Ebonyi AO, Ugoagwu P, Ojeh VB, Nasir N, Falang KD, Olaitan O, Agbaji O, Idoko J, Kanki P.

J Int Assoc Provid AIDS Care. 2015 Jan 7. pii: 2325957414565508. [Epub ahead of print]

PMID:
25566781
5.

The art of observation.

Coomer K.

Occup Med (Lond). 2015 Jan;65(1):71. doi: 10.1093/occmed/kqu148. No abstract available.

PMID:
25559794
6.

Durability of first antiretroviral treatment in HIV chronically infected patients: why change and what are the outcomes?

Moniz P, Alçada F, Peres S, Borges F, Baptista T, Miranda AC, Antunes I, Aldir I, Ventura F, Nina J, Mansinho K.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19797. doi: 10.7448/IAS.17.4.19797. eCollection 2014.

7.

Electronic medical record systems are associated with appropriate placement of HIV patients on antiretroviral therapy in rural health facilities in Kenya: a retrospective pre-post study.

Oluoch T, Katana A, Ssempijja V, Kwaro D, Langat P, Kimanga D, Okeyo N, Abu-Hanna A, de Keizer N.

J Am Med Inform Assoc. 2014 Nov-Dec;21(6):1009-14. doi: 10.1136/amiajnl-2013-002447. Epub 2014 Jun 9.

8.

Engagement in HIV care among Kenyan adults and adolescents: results from a national population-based survey.

Wafula R, Masyuko S, Ng'ang'a L, Kim AA, Gichangi A, Mukui I, Batuka J, Ngugi EW, Maina WK, Schwarcz S; KAIS Study Group.

J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1:S98-105. doi: 10.1097/QAI.0000000000000119.

PMID:
24732825
9.

Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey.

Odhiambo JO, Kellogg TA, Kim AA, Ng'ang'a L, Mukui I, Umuro M, Mohammed I, De Cock KM, Kimanga DO, Schwarcz S; KAIS Study Group.

J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1:S116-22. doi: 10.1097/QAI.0000000000000122.

PMID:
24732815
10.
11.

Incidence and predictors of first line antiretroviral regimen modification in western Kenya.

Inzaule S, Otieno J, Kalyango J, Nafisa L, Kabugo C, Nalusiba J, Kwaro D, Zeh C, Karamagi C.

PLoS One. 2014 Apr 2;9(4):e93106. doi: 10.1371/journal.pone.0093106. eCollection 2014.

12.

Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy.

Newman LP, Njoroge A, Ben-Youssef L, Merkel M, Gatuguta A, Ton Q, Obimbo EM, Wamalwa D, Lohman-Payne B, Richardson BA, Nduati R, Farquhar C.

Pediatr Infect Dis J. 2014 Aug;33(8):843-5. doi: 10.1097/INF.0000000000000332.

PMID:
24618938
13.

Durability of the first antiretroviral treatment regimen and reasons for change in patients with HIV infection.

De La Torre-Lima J, Aguilar A, Santos J, Jiménez-Oñate F, Marcos M, Núñez V, Olalla J, Del Arco A, Prada JL; Málaga Infectious Disease Group.

HIV Clin Trials. 2014 Jan-Feb;15(1):27-35. doi: 10.1310/hct1501-27.

PMID:
24518212
14.

The spectrum of eye disease in hospitalized adults living with HIV, 1995-2010.

Miller C, Short WR, Perez-Povis L, Lontok J, Fecarotta C, Liu M, Sendecki J, Belden K.

AIDS Patient Care STDS. 2014 Feb;28(2):47-55. doi: 10.1089/apc.2013.0258. Epub 2014 Feb 3.

PMID:
24491190
15.

Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India.

Pujari SN, Makane A, Lodha A, Bele V, Joshi K.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e82-4. doi: 10.1097/QAI.0b013e3182a6104a. No abstract available.

PMID:
24442229
16.

Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.

Shen Y, Wang J, Qi T, Wang Z, Lu H.

Int J STD AIDS. 2013 Dec 10;25(7):504-510. [Epub ahead of print]

PMID:
24327726
17.

Screening for HIV-associated peripheral neuropathy in resource-limited settings.

Cettomai D, Kwasa JK, Birbeck GL, Price RW, Cohen CR, Bukusi EA, Kendi C, Meyer AC.

Muscle Nerve. 2013 Oct;48(4):516-24. doi: 10.1002/mus.23795. Epub 2013 Aug 27.

18.

Risk factors for mortality in a south Indian population on generic antiretroviral therapy.

Rupali P, Mannam S, Bella A, John L, Rajkumar S, Clarence P, Pulimood SA, Samuel P, Karthik R, Abraham OC, Mathai D.

J Assoc Physicians India. 2012 Dec;60:11-4.

PMID:
23781664
19.

HIV mortality in urban slums of Nairobi, Kenya 2003-2010: a period effect analysis.

Oti SO, Mutua M, Mgomella GS, Egondi T, Ezeh A, Kyobutungi C.

BMC Public Health. 2013 Jun 17;13:588. doi: 10.1186/1471-2458-13-588.

20.

A side door into care cascade for HIV-infected patients?

Hallett TB, Eaton JW.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S228-32. doi: 10.1097/QAI.0b013e318298721b.

PMID:
23764640
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk